The purpose of this study is to determine the change in median radiation exposure time and median procedure time following guided radiofrequency (RF) ablation among subjects undergoing treatment for paroxysmal atrial fibrillation with either the CARTO® 3 or the NavX(TM) System. It is hypothesized that described features will reduce the median radiation exposure during the CARTO® 3 system-guided procedures compared to the NavX(TM) system-guided procedures.
Study Type
OBSERVATIONAL
Enrollment
107
Generating a cardiac map using the study device (CARTO 3) compared to the control device (NAVX\[TM\]) and measuring the amount of radiation exposure duration for each.
Vancouver Island Health Authority - Royal Jubilee Hospital
Victoria, British Columbia, Canada
QE II Health Sciences Center
Halifax, Nova Scotia, Canada
London Health Sciences
London, Ontario, Canada
Southlake Regional Healthcare Centre
Newmarket, Ontario, Canada
Total Fluoroscopy Time
The primary outcome measure of this study is to measure and compare total fluoroscopy exposure time (minutes) at the conclusion of radiofrequency ablation for the treatment of paroxysmal atrial fibrillation, when guided by the CARTO® 3 or the NavX(TM) System in similar procedures.
Time frame: Throughout the Total Duration of the Procedure
Total Procedure Time
Time frame: Total Duration of the Procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
St. Michael's Hospital
Toronto, Ontario, Canada
Laval Hopital
Québec, Quebec, Canada